Your browser doesn't support javascript.
loading
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya, Ksenia; Königshofer, Philipp; Lampach, Daniel; Szodl, Adrian; Supper, Paul; Bauer, David; Beer, Andrea; Stift, Judith; Timelthaler, Gerald; Oberhuber, Georg; Podesser, Bruno Karl; Seif, Martha; Zinober, Kerstin; Rohr-Udilova, Nataliya; Trauner, Michael; Reiberger, Thomas; Schwabl, Philipp.
Afiliación
  • Brusilovskaya K; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Königshofer P; Vienna Hepatic Haemodynamic Lab (HEPEX), Medical University of Vienna, Vienna, Austria.
  • Lampach D; Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
  • Szodl A; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
  • Supper P; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Bauer D; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Beer A; Vienna Hepatic Haemodynamic Lab (HEPEX), Medical University of Vienna, Vienna, Austria.
  • Stift J; Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
  • Timelthaler G; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
  • Oberhuber G; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Podesser BK; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Seif M; Vienna Hepatic Haemodynamic Lab (HEPEX), Medical University of Vienna, Vienna, Austria.
  • Zinober K; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Rohr-Udilova N; Vienna Hepatic Haemodynamic Lab (HEPEX), Medical University of Vienna, Vienna, Austria.
  • Trauner M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Reiberger T; Vienna Hepatic Haemodynamic Lab (HEPEX), Medical University of Vienna, Vienna, Austria.
  • Schwabl P; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
United European Gastroenterol J ; 8(10): 1174-1185, 2020 12.
Article en En | MEDLINE | ID: mdl-32878579
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Inhibidores de Fosfodiesterasa 5 / Guanilil Ciclasa Soluble / Hipertensión Portal / Cirrosis Hepática Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: En Revista: United European Gastroenterol J Año: 2020 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Inhibidores de Fosfodiesterasa 5 / Guanilil Ciclasa Soluble / Hipertensión Portal / Cirrosis Hepática Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Idioma: En Revista: United European Gastroenterol J Año: 2020 Tipo del documento: Article País de afiliación: Austria